000 01819 a2200481 4500
005 20250516071056.0
264 0 _c20120416
008 201204s 0 0 eng d
022 _a1432-1335
024 7 _a10.1007/s00432-011-1113-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhai, Feng-Xian
245 0 0 _aRUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines.
_h[electronic resource]
260 _bJournal of cancer research and clinical oncology
_cMar 2012
300 _a439-49 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aAzacitidine
_xadministration & dosage
650 0 4 _aBlotting, Western
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCore Binding Factor Alpha 3 Subunit
_xmetabolism
650 0 4 _aCpG Islands
650 0 4 _aFluorescent Antibody Technique
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xadministration & dosage
650 0 4 _aK562 Cells
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aUp-Regulation
700 1 _aLiu, Xiang-Fu
700 1 _aFan, Rui-Fang
700 1 _aLong, Zi-Jie
700 1 _aFang, Zhi-Gang
700 1 _aLu, Ying
700 1 _aZheng, Yong-Jiang
700 1 _aLin, Dong-Jun
773 0 _tJournal of cancer research and clinical oncology
_gvol. 138
_gno. 3
_gp. 439-49
856 4 0 _uhttps://doi.org/10.1007/s00432-011-1113-y
_zAvailable from publisher's website
999 _c21400781
_d21400781